
Jack Higgins
Chief Scientific Officer · Immunome Inc.
- 2025
- Sep 15, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jack Higgins files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Isaac Barchas - $9.94M in IMNM purchases and sales in the last 12 months
- Max Rosett - $2.52M in IMNM purchases and sales in the last 12 months
- Robert Lechleider - $2.34M in IMNM purchases and sales in the last 12 months
- Kinney Horn - $2.30M in IMNM purchases and sales in the last 12 months
- Philip Wagenheim - $1.34M in IMNM purchases and sales in the last 12 months
- Jean Jacques Bienaime - $555K in IMNM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jack Higgins?
Jack Higgins is a corporate insider, tracked as Chief Scientific Officer of Immunome Inc. (IMNM). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jack Higgins submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jack Higgins been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($538K) across all tracked filings.